Biomarkers in Alzheimer’s Disease
Open Access
- 1 January 2011
- journal article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 2, 46
- https://doi.org/10.3389/fneur.2011.00046
Abstract
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, and it is characterized by progressive impairment in multiple cognitive domains of sufficient severity to interfere with individuals’ daily living activities. Historically, the diagnosis of AD has been based on the identification of a clinical syndrome, and accuracy studies of the current clinical criteria conducted in referral clinics have shown high sensitivity for AD. However, the identification of the disease is still not perfect, and there is growing evidence that the use of biomarkers will increase our ability to better indentify the underlying biology of AD, especially in its early stages. These biomarkers will improve the detection of the patients suitable for research studies and drug trials, and they will contribute to a better management of the disease in the clinical practice. In this review, we discuss the most studied biomarkers in AD: cerebrospinal fluid proteins, structural magnetic resonance imaging, functional neuroimaging techniques, and amyloid imaging.This publication has 102 references indexed in Scilit:
- Hippocampal hypometabolism predicts cognitive decline from normal agingNeurobiology of Aging, 2008
- Cerebrospinal fluid -amyloid 1-42 concentration may predict cognitive decline in older womenJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairmentJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography studyAnnals of Neurology, 2006
- CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementiaBrain, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2006
- Core biological marker candidates of Alzheimer?s disease ? perspectives for diagnosis, prediction of outcome and reflection of biological activityJournal of Neural Transmission, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984